These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34519532)

  • 1. Gut Metabolites Are More Predictive of Disease and Cohoused States than Gut Bacterial Features in a Polycystic Ovary Syndrome-Like Mouse Model.
    Ho B; Ryback D; Benson B; Mason CN; Torres PJ; Quinn RA; Thackray VG; Kelley ST
    mSystems; 2021 Oct; 6(5):e0114920. PubMed ID: 34519532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to a Healthy Gut Microbiome Protects Against Reproductive and Metabolic Dysregulation in a PCOS Mouse Model.
    Torres PJ; Ho BS; Arroyo P; Sau L; Chen A; Kelley ST; Thackray VG
    Endocrinology; 2019 May; 160(5):1193-1204. PubMed ID: 30924862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome.
    Arroyo P; Ho BS; Sau L; Kelley ST; Thackray VG
    PLoS One; 2019; 14(9):e0223274. PubMed ID: 31568518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of metabolic and microbial influences on women with polycystic ovarian syndrome.
    Ravat FK; Goswami JR; Nair SM; Thummar KN
    Steroids; 2024 Dec; 212():109512. PubMed ID: 39278517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics analyses reveal the specific changes in gut metagenome and serum metabolome of patients with polycystic ovary syndrome.
    Yang Z; Fu H; Su H; Cai X; Wang Y; Hong Y; Hu J; Xie Z; Wang X
    Front Microbiol; 2022; 13():1017147. PubMed ID: 36338055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated fecal microbiota and metabolomics analysis of the orlistat intervention effect on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet.
    Yang J; Wang E; Jiang M; Tan Y; Yao F; Sun C; Pan L; Gao L; Yao J
    J Ovarian Res; 2023 Jun; 16(1):109. PubMed ID: 37277785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism.
    Torres PJ; Siakowska M; Banaszewska B; Pawelczyk L; Duleba AJ; Kelley ST; Thackray VG
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1502-1511. PubMed ID: 29370410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intersection of Polycystic Ovary Syndrome and the Gut Microbiome.
    Rizk MG; Thackray VG
    J Endocr Soc; 2021 Feb; 5(2):bvaa177. PubMed ID: 33381671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
    Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
    Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
    Li P; Shuai P; Shen S; Zheng H; Sun P; Zhang R; Lan S; Lan Z; Jayawardana T; Yang Y; Zhao J; Liu Y; Chen X; El-Omar EM; Wan Z
    BMC Med; 2023 Aug; 21(1):302. PubMed ID: 37559119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome but Affects Amino Acid Metabolism in Sera of Obese Girls With Polycystic Ovary Syndrome.
    Tayachew B; Vanden Brink H; Garcia-Reyes Y; Rahat H; D'Alessandro A; Frank DN; Robertson CE; Silveira L; Kelsey M; Pyle L; Cree-Green M
    Front Physiol; 2022; 13():887077. PubMed ID: 35800349
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome.
    Pieczyńska-Zając JM; Malinowska AM; Pruszyńska-Oszmałek E; Kołodziejski PA; Drzymała-Czyż S; Bajerska J
    Nutrition; 2024 Aug; 124():112450. PubMed ID: 38669829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.
    Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Leber B; Horvath A; Pieber TR; Gorkiewicz G; Stadlbauer V; Obermayer-Pietsch B
    PLoS One; 2017; 12(1):e0168390. PubMed ID: 28045919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay between PCOS pathology and diet on gut microbiota in a mouse model.
    Rodriguez Paris V; Wong XYD; Solon-Biet SM; Edwards MC; Aflatounian A; Gilchrist RB; Simpson SJ; Handelsman DJ; Kaakoush NO; Walters KA
    Gut Microbes; 2022; 14(1):2085961. PubMed ID: 35787106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review.
    Mukherjee AG; Wanjari UR; Kannampuzha S; Murali R; Namachivayam A; Ganesan R; Dey A; Babu A; Renu K; Vellingiri B; Ramanathan G; Priya Doss C G; Elsherbiny N; Elsherbini AM; Alsamman AM; Zayed H; Gopalakrishnan AV
    Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome.
    Zhou L; Ni Z; Yu J; Cheng W; Cai Z; Yu C
    Front Endocrinol (Lausanne); 2020; 11():628. PubMed ID: 33013704
    [No Abstract]   [Full Text] [Related]  

  • 17. Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome.
    Chu W; Han Q; Xu J; Wang J; Sun Y; Li W; Chen ZJ; Du Y
    Fertil Steril; 2020 Jun; 113(6):1286-1298.e4. PubMed ID: 32482258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome.
    Kelley ST; Skarra DV; Rivera AJ; Thackray VG
    PLoS One; 2016; 11(1):e0146509. PubMed ID: 26731268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of Gut Microbiome and Fecal Fatty Acids in Patients With Polycystic Ovary Syndrome in Central China.
    Li G; Liu Z; Ren F; Shi H; Zhao Q; Song Y; Fan X; Ma X; Qin G
    Front Microbiol; 2022; 13():911992. PubMed ID: 35847083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
    Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
    Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.